The isolation and determination of neostigmine, pyridostigmine and their metabolites in human biological fluids

Barber, 1972, The use of liquid cation exchange in the extraction and separation of 14C neostigmine iodide and its metabolite 14C 3-hydroxyphenyltrimethylammonium iodide from body fluids, J Pharm Pharmacol, 24, 907, 10.1111/j.2042-7158.1972.tb08913.x Beckett, 1966, Drug distribution and metabolism, Dansk Tidsskr Farm, 40, 197 Calvey, 1977, Plasma concentration and pharmacological effects of pyridostigmine in patients with myasthenia gravis, Br J Clin Pharmacol, 4, 404P, 10.1111/j.1365-2125.1977.tb00750.x Calvey, 1976, Plasma pyridostigmine levels in patients with myasthenia gravis, Clin Pharmacol Ther, 21, 187, 10.1002/cpt1977212187 Chan, 1977, The TLC separation of the metabolites of pyridostigmine from the urine of myasthenic patients Chan, 1976, A quantitative gas-liquid chromatographic method for the determination of neostigmine and pyridostigmine in human plasma, J Chromatog, 120, 349, 10.1016/S0021-9673(76)80012-X Jonkmann, 1974, The bioavailability of quaternary multergan, J Pharm Pharmacol, 26, 63P Miller, 1976, Antagonism of neuromuscular blockade, Anesthesiol, 44, 318, 10.1097/00000542-197604000-00010 Pohlmann, 1977, Simplified detection of quaternary ammonium compounds by gas chromatography, J Chromatog, 131, 297, 10.1016/S0021-9673(00)80945-0 Szilagyi, 1972, The measurement of nanogram amounts of acetylcholine in tissues by pyrolysis gas chromatography, J Neurochem, 19, 2555, 10.1111/j.1471-4159.1972.tb01314.x